KRESLADI
Live / Applied — Third extension granted (statement of use) (as of 17 Dec 2025)
What this means for you
Not registered yet, but its 02 Oct 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98205828
- Mark type
- Stylized text
- Filed
- 02 Oct 2023
- Published for opposition
- 23 Apr 2024
- Attorney of record
- Danny M. Awdeh
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of genetic diseases and disorders
- Class 042 — Scientific and technological services: Research and development of pharmaceuticals for the treatment of genetic diseases and disorders; medical and scientific research services in the field of genetic disease and disorder treatment
- Class 044 — Medical, beauty and agricultural services: Providing information in the field of genetic diseases and disorders; providing information in the field of genetic diseases and disorders treatment; Providing links to the web sites of others featuring information about genetic diseases and disorders; providing links to the web sites of others in the field of the diagnosis and treatment of genetic diseases and disorders
Owner
- Rocket Pharmaceuticals GmbH, Zug, CH
- Rocket Pharmaceuticals GmbH, Zug, CH
Prosecution history
- 18 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Dec 2025 — SOU EXTENSION 3 GRANTED
- 17 Dec 2025 — SOU EXTENSION 3 FILED
- 17 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 17 Jun 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Jun 2025 — SOU EXTENSION 2 GRANTED
- 16 Jun 2025 — SOU EXTENSION 2 FILED
- 16 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 01 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Oct 2024 — SOU EXTENSION 1 GRANTED
- 01 Oct 2024 — SOU EXTENSION 1 FILED
- 01 Oct 2024 — SOU TEAS EXTENSION RECEIVED
- 18 Jun 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 23 Apr 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 23 Apr 2024 — PUBLISHED FOR OPPOSITION